POST-DOCTORAL PHARMACEUTICAL INDUSTRY FELLOWSHIP – Rutgers, The State University of New Jersey, Ernest Mario School of Pharmacy, has over 40 years of expertise in offering innovative Post-Doctoral Pharm.D. Fellowships that provide extensive training in the pharmaceutical and biopharmaceutical industry. This 2-year Fellowship position is a joint effort between the Rutgers Institute for Pharmaceutical Industry Fellowships (RPIF) and Bristol Myers Squibb. Program emphasis is in WW Immunology and Neuroscience Medical Communications & Medical Strategy. This 2-year Fellowship provides a unique opportunity to work across the Medical Communications and Medical Strategy functions within the Worldwide Medical organization. The Fellow will learn how to communicate key clinical and economic data across various channels to inform healthcare decision-making. Within this role, the Fellow will gain experience in the generation of strategic and prioritized scientific publications, content, and medical education for HCPs and patients. While doing so, the Fellow will become adept in the planning and execution of scientific communication deliverables, including but not limited to, journal publications, congress presentations, reactive slide decks, FAQ, standard response documents, and dossiers. In the second year, the Fellow will gain a broader understanding of Medical Affairs through participation and leadership in experiences from the perspective of the Worldwide Medical Strategy team. The Fellow will engage in developing and executing strategic initiatives including advisory boards, identifying educational needs, and data generation plans to ensure alignment with the immunology strategic imperative. This position encourages the cultivation of critical thinking and leadership skills through cross-functional collaboration with various internal and external stakeholders (e.g., Medical Strategy, Medical Information, Health Economics and Outcomes Research (HEOR), Field Medical, Clinical Development, Clinical Science, Field HEOR, Legal and third-party vendors). Key activities and learnings will include:
MEDICAL COMMUNICATIONS
Understand the unique information needs of healthcare professionals, payers, access influencers, and patients to ensure strategic and prioritized information delivery
Collaborate with WW & US Medical Strategy, HEOR, medical field teams, and other stakeholders to ensure development of fair-balanced scientific content with the highest degree of medical integrity, accuracy, and clinical relevance
Lead content creation of medical communication deliverables involving clinical studies, economic analyses, and real-world evidence pertaining to BMS medicines. Deliverables include reactive slide decks, standard response documents, Q&A documents for medical field teams, and responses to medical information inquiries
Gain experience through collaboration with WW and US Medical Strategy, HEOR, and other stakeholders in developing strategic and impactful clinical and HEOR publications for BMS assets
In collaboration with WW & US Medical Strategy, external authors, and appropriate internal stakeholders, develop publications adhering to BMS publication standards including abstracts, congress presentations, and manuscripts focused on disease burden, unmet medical needs, and the clinical and economic value of BMS assets
Lead the execution of publication plans and develop skills for managing stakeholders, both external and internal, in multiple functional areas to ensure strategic alignment of the publication plans
MEDICAL STRATEGY
Participate in the Medical Matrix Team to support strategic planning based on the unmet medical needs from the perspectives of patients, providers, and payers
Collaborate with cross-functional medical team members to deliver on key medical initiatives including advisory boards, proactive messaging, reactive medical communication, and publication strategy
Review promotional and non-promotional materials alongside Legal, Regulatory, and Marketing teams
Engage with external Thought Leaders to exchange and gather scientific and clinical knowledge through investigator meetings, advisory boards, Thought Leader Engagements (TLEs), publication planning, and congresses
University-based experiences complement the industry experiences and include a Professional Development Series; opportunities for collaborative research, publication, and teaching; and participating/leading Rutgers Fellowship committees. These Fellowships provide a broad professional development opportunity in both corporate and academic environments to promote the role of Pharm.D.’s in the pharmaceutical and biopharmaceutical industry and help fuel your career as a future leader. For more information and to apply, please visit our website: http://pharmafellows.rutgers.edu
Do not click the “Apply Now” button to the right. We do not accept applications or schedule interviews with the PPS system, so please do not request an interview through this website. You can only apply at http://pharmafellows.rutgers.edu
The RPIF Program application portal opens at 9 AM ET on October 11th. Initial interviews will be conducted on a rolling basis virtually (video conference) starting October 21st. To apply, candidates MUST use the RPIF website (http://pharmafellows.rutgers.edu/how-to-apply/) to create a RPIF Candidate Account and upload the required application materialsby the dates noted below.Remember that the application process is on a rolling basis, so earlier is better. Please see our website for additional important recruitment information and dates.
Initial offers will not be made until December 16th, the AIFA (Alliance of Industry Fellowship Associates) consensus date for first offers. Once all interviews have been completed, RPIF or the company will notify interviewed candidates of their position-specific candidacy status.
Candidate Checklist:
Create an RPIF Candidate Account starting now.
Upload RPIF Application Materials to RPIF Candidate Account starting October 11, 2024.
Applications are considered on a rolling basis. The earlier you submit materials, the sooner your candidacy can be considered. Complete the brief RPIF portal short-answer questions and you should upload your Letter of Intent and Curriculum Vitae (CV) by October 18, 2024.
Begin securing letters of recommendation because all 3 must be received before you can be fully considered for an offer. All 3 letters of recommendation should be submitted by December 1, 2024.
RPIF Representatives may reach out to schedule an interview. Please ensure your contact information is up to date.
As a University, Rutgers recognizes that the diversity of its workforce should reflect the diversity of the State and the students we serve. We strive to cultivate a culture of inclusion at Rutgers – one in which individuals of various backgrounds and belief systems can come together in an environment of mutual respect, learning from each other, and becoming better-prepared to participate in an increasingly globalized marketplace of ideas.
Rutgers University follows a policy to provide equal employment opportunity to all its employees and applicants for employment regardless of their race, creed, color, national origin, age, ancestry, nationality, marital or domestic partnership or civil union status, sex, pregnancy, gender identity or expression, disability status, liability for military service, protected veteran status, affectional or sexual orientation, atypical cellular or blood trait, genetic information (including the refusal to submit to genetic testing), or any other category protected by law.
The Ernest Mario School of Pharmacy at Rutgers, The State University of New Jersey, is dedicated to excellence in healthcare and biomedical education, innovative and visionary research and scholarship in the pharmaceutical sciences, exemplary clinical practice, and outreach and community services that address the needs of the citizens of New Jersey and society at large.
The School has a historic and profound commitment to public service – to pharmacists, the pharmaceutical industry, the health care community, government agencies, and the citizens of New Jersey.